Document is current
Any future updates will be listed below
-
Authors
Wang, Yan
Sun, Kaiyuan
Feng, Zhaomin
Yi, Lan
Wu, Yanpeng
Liu, Hengcong
Wang, Quanyi
Ajelli, Marco
Viboud, Cécile
Yu, Hongjie
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82130093)
- License Information
-
More Information
Article History
Received: 3 July 2022
Accepted: 26 October 2022
First Online: 15 November 2022
Declarations
:
: Not applicable.
: Not applicable.
: HY received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, Shanghai Roche Pharmaceutical Company, and SINOVAC Biotech Ltd. Except for research funding from SINOVAC Biotech Ltd, which is related to the data analysis of clinical trials of immunogenicity and safety of CoronaVac, the others are not related to COVID-19. All the other authors have no competing interests.
